Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1993 Mar;37(3):491–494. doi: 10.1128/aac.37.3.491

In vitro activities of ceftriaxone and fusidic acid against 13 isolates of Coxiella burnetii, determined using the shell vial assay.

H Torres 1, D Raoult 1
PMCID: PMC187697  PMID: 8460917

Abstract

The susceptibilities of 13 isolates of Coxiella burnetii to fusidic acid and ceftriaxone were determined by use of the recently described shell vial assay (D. Raoult, H. Torres, and M. Drancourt, Antimicrob. Agents Chemother, 35:2070-2077, 1991). At a concentration of 4 micrograms/ml, ceftriaxone was bacteriostatic for four isolates and slowed the multiplication of the other nine. Fusidic acid at a concentration of 2 micrograms/ml was bacteriostatic for six isolates and slowed the multiplication of three others. These results show that these compounds could be effective in the phagolysosome of C. burnetii-infected cells.

Full text

PDF
491

Images in this article

493Image
on p.493

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bergeron M. G., Desaulniers D., Lessard C., Lemieux M., Després J. P., Métras J., Raymond G., Brochu G. Concentrations of fusidic acid, cloxacillin, and cefamandole in sera and atrial appendages of patients undergoing cardiac surgery. Antimicrob Agents Chemother. 1985 Jun;27(6):928–932. doi: 10.1128/aac.27.6.928. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bosch J., Liñares J., López de Goicoechea M. J., Ariza J., Cisnal M. C., Martin R. In-vitro activity of ciprofloxacin, ceftriaxone and five other antimicrobial agents against 95 strains of Brucella melitensis. J Antimicrob Chemother. 1986 Apr;17(4):459–461. doi: 10.1093/jac/17.4.459. [DOI] [PubMed] [Google Scholar]
  3. Eykyn S. J. The treatment of staphylococcal endocarditis. J Antimicrob Chemother. 1987 Sep;20 (Suppl A):161–171. doi: 10.1093/jac/20.suppl_a.161. [DOI] [PubMed] [Google Scholar]
  4. Franzblau S. G., Biswas A. N., Harris E. B. Fusidic acid is highly active against extracellular and intracellular Mycobacterium leprae. Antimicrob Agents Chemother. 1992 Jan;36(1):92–94. doi: 10.1128/aac.36.1.92. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. GODTFREDSEN W., ROHOLT K., TYBRING L. Fucidin: a new orally active antibiotic. Lancet. 1962 May 5;1(7236):928–931. doi: 10.1016/s0140-6736(62)91968-2. [DOI] [PubMed] [Google Scholar]
  6. Hackstadt T. The role of lipopolysaccharides in the virulence of Coxiella burnetii. Ann N Y Acad Sci. 1990;590:27–32. doi: 10.1111/j.1749-6632.1990.tb42203.x. [DOI] [PubMed] [Google Scholar]
  7. Hammerschlag M. R., Gleyzer A. In vitro activity of a group of broad-spectrum cephalosporins and other beta-lactam antibiotics against Chlamydia trachomatis. Antimicrob Agents Chemother. 1983 Mar;23(3):493–494. doi: 10.1128/aac.23.3.493. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hierholzer G., Rehn J., Knothe H., Masterson J. Antibiotic therapy of chronic post-traumatic osteomyelitis. J Bone Joint Surg Br. 1974 Nov;56-B(4):721–729. doi: 10.1302/0301-620X.56B4.721. [DOI] [PubMed] [Google Scholar]
  9. Kuhn H., Angehrn P., Havas L. Autoradiographic evidence for penetration of 3H-ceftriaxone (Rocephin) into cells of spleen, liver and kidney of mice. Chemotherapy. 1986;32(2):102–112. doi: 10.1159/000238398. [DOI] [PubMed] [Google Scholar]
  10. Micoud M., Brion J. P., Boulard J. C., Magne J. L., Gratacap B., Stahl J. P., Farah I., Raoult D. Infection of aortic aneurysm with Coxiella burnetii. Lancet. 1991 Aug 31;338(8766):584–584. doi: 10.1016/0140-6736(91)91161-m. [DOI] [PubMed] [Google Scholar]
  11. Palenque E., Otero J. R., Noriega A. R. In vitro susceptibility of Brucella melitensis to new cephalosporins crossing the blood-brain barrier. Antimicrob Agents Chemother. 1986 Jan;29(1):182–183. doi: 10.1128/aac.29.1.182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Raoult D. Antibiotic treatment of rickettsiosis, recent advances and current concepts. Eur J Epidemiol. 1991 May;7(3):276–281. doi: 10.1007/BF00145677. [DOI] [PubMed] [Google Scholar]
  13. Raoult D., Bollini G., Gallais H. Osteoarticular infection due to Coxiella burnetii. J Infect Dis. 1989 Jun;159(6):1159–1160. doi: 10.1093/infdis/159.6.1159. [DOI] [PubMed] [Google Scholar]
  14. Raoult D., Drancourt M., Vestris G. Bactericidal effect of doxycycline associated with lysosomotropic agents on Coxiella burnetii in P388D1 cells. Antimicrob Agents Chemother. 1990 Aug;34(8):1512–1514. doi: 10.1128/aac.34.8.1512. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Raoult D., Etienne J., Massip P., Iaocono S., Prince M. A., Beaurain P., Benichou S., Auvergnat J. C., Mathieu P., Bachet P. Q fever endocarditis in the south of France. J Infect Dis. 1987 Mar;155(3):570–573. doi: 10.1093/infdis/155.3.570. [DOI] [PubMed] [Google Scholar]
  16. Raoult D., Piquet P., Gallais H., de Micco C., Drancourt M., Casanova P. Coxiella burnetii infection of a vascular prosthesis. N Engl J Med. 1986 Nov 20;315(21):1358–1359. [PubMed] [Google Scholar]
  17. Raoult D., Torres H., Drancourt M. Shell-vial assay: evaluation of a new technique for determining antibiotic susceptibility, tested in 13 isolates of Coxiella burnetii. Antimicrob Agents Chemother. 1991 Oct;35(10):2070–2077. doi: 10.1128/aac.35.10.2070. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Raoult D., Vestris G., Enea M. Isolation of 16 strains of Coxiella burnetii from patients by using a sensitive centrifugation cell culture system and establishment of the strains in HEL cells. J Clin Microbiol. 1990 Nov;28(11):2482–2484. doi: 10.1128/jcm.28.11.2482-2484.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Reeves D. S. The pharmacokinetics of fusidic acid. J Antimicrob Chemother. 1987 Oct;20(4):467–476. doi: 10.1093/jac/20.4.467. [DOI] [PubMed] [Google Scholar]
  20. Ruckdeschel G., Ehret W., Ahl A. Susceptibility of Legionella spp. to imipenem and 27 other beta-lactam antibiotics. Eur J Clin Microbiol. 1984 Oct;3(5):463–467. doi: 10.1007/BF02017376. [DOI] [PubMed] [Google Scholar]
  21. Steinkraus G. E., McCarthy L. R. In vitro activity of sodium fusidate against anaerobic bacteria. Antimicrob Agents Chemother. 1979 Aug;16(2):120–122. doi: 10.1128/aac.16.2.120. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Talbot H., Romanowski B. In vitro activities of lomefloxacin, tetracycline, penicillin, spectinomycin, and ceftriaxone against Neisseria gonorrhoeae and Chlamydia trachomatis. Antimicrob Agents Chemother. 1989 Dec;33(12):2049–2051. doi: 10.1128/aac.33.12.2049. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Traub W. H., Spohr M. In vitro antibiotic susceptibility of Legionellaceae: search for alternative antimicrobial drugs. Chemotherapy. 1984;30(3):182–187. doi: 10.1159/000238266. [DOI] [PubMed] [Google Scholar]
  24. Yeaman M. R., Roman M. J., Baca O. G. Antibiotic susceptibilities of two Coxiella burnetii isolates implicated in distinct clinical syndromes. Antimicrob Agents Chemother. 1989 Jul;33(7):1052–1057. doi: 10.1128/aac.33.7.1052. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES